01 1Nobilus Ent Tomasz Kozluk
01 1Masung LS Co., Ltd.
01 1Digoxin
01 1Poland
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2021-03-09
Registration Number : 20210309-209-J-739
Manufacturer Name : Nobilus Ent Tomasz Kozluk
Manufacturer Address : ul. Metalowa 6a, 99-300 Kutno, Poland
42
PharmaCompass offers a list of Digoxin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Digoxin manufacturer or Digoxin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Digoxin manufacturer or Digoxin supplier.
A Lanitop manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lanitop, including repackagers and relabelers. The FDA regulates Lanitop manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lanitop API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lanitop manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Lanitop supplier is an individual or a company that provides Lanitop active pharmaceutical ingredient (API) or Lanitop finished formulations upon request. The Lanitop suppliers may include Lanitop API manufacturers, exporters, distributors and traders.
click here to find a list of Lanitop suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lanitop Drug Master File in Korea (Lanitop KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lanitop. The MFDS reviews the Lanitop KDMF as part of the drug registration process and uses the information provided in the Lanitop KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lanitop KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lanitop API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lanitop suppliers with KDMF on PharmaCompass.
